• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Email
  • Facebook
  • Instagram
  • Twitter
  • YouTube

International Alliance of ALS/MND Associations

  • Members' Login
  • Contact
  • Join the Alliance
  • Donate
  • What is ALS/MND
  • Find a Member Association
  • Support for PALS & CALS
    • Advocacy
      • Fundamental Rights of People with ALS/MND and Caregivers
      • Advocacy Toolkit
      • Understanding ALS/MND Research
      • Improving Regulatory Pathways
      • Right to Try
      • US FDA Orphan Drug Designation
      • Unproven (Off-Label) Treatments
      • Open Label Extension
      • Expanded Access
    • Care Services
      • Genetic Counselling & Testing
      • Mental Health Support
      • Nursing and Symptom Management
      • Nutrition and Swallowing
      • Occupational Therapy and Activities of Daily Living
      • Physiotherapy and Mobility
      • Respiratory Care
      • Speech Therapy and Communication
      • Support for Family & Caregivers
      • Technology
    • Drugs in Clinical Trial
      • Amylyx – AMX0035
      • Biogen – Tofersen
      • BrainStorm Cell Therapeutics – NurOwn
      • Clene Nanomedicine – CNM-Au8
      • Collaborative Medicinal Development – CuATSM
      • Cytokinetics – Reldesemtiv
      • Kadimastem – AstroRx
      • Mitsubishi Tanabe Pharma America – Oral Edaravone
      • Orphazyme – Arimoclomol
      • T Regulatory Cell Therapies
    • Approved Drugs
      • Riluzole/Tiglutik
      • Radicava/Edaravone
      • Neudexta
  • Events/Programs
    • Calendar of Events/Programs
    • Alliance Webinars
    • Alliance Meeting
    • Allied Professionals Forum
    • ALS/MND Connect
    • Global Day
    • March of Faces
    • International Symposium on ALS/MND
  • About
    • Who We Are
    • Board of Directors
    • Committees/Advisory Councils
      • Scientific Advisory Council
      • PALS and CALS Advisory Council
      • Innovation and Technology Council
      • Governance Committee
      • Budget and Finance Committee
    • Staff
    • History
    • Archives
      • Newsletters
      • Meetings
    • Awards
  • Members
    • Member Registration
    • Forgot Password

ALS Netherlands

Netherlands
Date founded: 1 January 2005
Region covered:

The Netherlands


Address:

Koninginnegracht 7
2514 AA The Hague
The Netherlands


ALS Netherlands Activities

  • Granting (financial) support to and promotion of research to causes of ALS and research to cure or prevent the disease
  • Increase of available knowledge in this area by stimulating scientific researching a broad sense, particularly aimed at the cause and the prevention of ALS, but also on treatment and rehabilitation of patients.
  • Making available information on the causes and treatment of ALS.
  • Promotion training of experts both in the medical and non-medical disciplines and promotion of additional studying to doctors and others involved in care of patients
  • Initiate and maintain contacts with institutions, organisations and agencies which can contribute to the fight of ALS/MND.
  • Initiate and maintain contacts, and cooperate with pharmaceutical companies in areas where they contribute to the fight of ALS/MND
  • Doing advocacy for people with ALS in the broadest sense of the word.
  • Maintain a knowledge centre on ALS.
  • Stimulate awareness of ALS.
  • Initiate, manage, develop funds to support all aforesaid objectives
  • All other activities that contribute to the goals and objectives goals and objectives.

The foundation tries to reach these goals and objectives by all legitimate resources, such as,

  • Acquiring and invest reinvesting resources, and securities and its revenues.
  • Acquiring donations, legacy and heritages.
  • Fund raising in a broad sense of the word.
  • Granting benefits or supply loans to persons or institutions operative or doing research in the field of ALS/MND.

ALS Netherlands Branches/Chapters

4

Contacts

  • Gorrit-Jan Blonk, Director
  • Marjan Sterenborg, Marketing & Communication Manager

Phone:

+31 886660333

Email:

info@als.nl

Website:

www.als.nl

Facebook:

www.facebook.com/ALSnederland

Twitter:

twitter.com/ALSnederland

YouTube:

www.youtube.com/user/StichtingALS

Primary Sidebar

Back to all

Subscribe to our Bi-Monthly Newsletter

Fill out the form below to subscribe to the Alliance’s bi-monthly newsletter, packed with updates from members associations from around the world!

Footer

Keep in touch

Sign up to receive updates and to hear what's going on in the International Alliance of ALS/MND Associations.

"*" indicates required fields

 
This field is for validation purposes and should be left unchanged.

  • Email
  • Facebook
  • Instagram
  • Twitter
  • YouTube
Return to top of page

Contact | Disclaimer | Privacy Notice & Cookies | Sitemap

Copyright © 2022 The International Alliance of ALS/MND Associations. All rights reserved.


Registered in England: Charity Number 1079504 · Site built by graphics.coop · Powered by WordPress · Members' login